Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon C Ling

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Pediatrics|October 21, 2015
Incidence and Characteristics of Autoimmune HepatitisCarolina Jiménez-Rivera, Simon C Ling, Najma Ahmed, et al.
Hepatology (Baltimore, Md.)|June 30, 2019
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA StudyMaureen M Jonas, Robert H Squires, Susan M Rhee, et al.
The Journal of Infectious Diseases|July 21, 2021
The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis BAlexandra Johnson Valiente, Kin Seng Liem, Kathleen B Schwarz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 16, 2026
Lack of clinical change in longitudinal vibration controlled transient elastography among children with cystic fibrosis and poor association with non-invasive biomarkers of liver diseaseWen Ye, Suiyuan Huang, Molly Bozic, et al.
Journal of Viral Hepatitis|April 12, 2019
Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis BAdrian M Di Bisceglie, Wendy C King, Mauricio Lisker-Melman, et al.
Hepatology (Baltimore, Md.)|April 3, 2021
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA StudyMaureen M Jonas, Susan Rhee, Deirdre A Kelly, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesisJaclyn R Stonebraker, Rhonda G Pace, Paul J Gallins, et al.
Hepatology (Baltimore, Md.)|November 7, 2023
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendationsZachary M Sellers, David N Assis, Shruti M Paranjape, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 26, 2025
Impact of elexacaftor/tezacaftor/ivacaftor on biomarkers of cystic fibrosis hepatobiliary involvement in the PUSH studyWen Ye, John C Magee, Suiyuan Huang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 9, 2023
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver diseaseMarilyn J Siegel, Daniel H Leung, Jean P Molleston, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Pediatrics|October 21, 2015
Incidence and Characteristics of Autoimmune HepatitisCarolina Jiménez-Rivera, Simon C Ling, Najma Ahmed, et al.
Hepatology (Baltimore, Md.)|June 30, 2019
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Adolescents With Chronic Hepatitis C Virus: Part 1 of the DORA StudyMaureen M Jonas, Robert H Squires, Susan M Rhee, et al.
The Journal of Infectious Diseases|July 21, 2021
The Inflammatory Cytokine Profile Associated With Liver Damage Is Broader and Stronger in Patients With Chronic Hepatitis B Compared to Patients With Acute Hepatitis BAlexandra Johnson Valiente, Kin Seng Liem, Kathleen B Schwarz, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 16, 2026
Lack of clinical change in longitudinal vibration controlled transient elastography among children with cystic fibrosis and poor association with non-invasive biomarkers of liver diseaseWen Ye, Suiyuan Huang, Molly Bozic, et al.
Journal of Viral Hepatitis|April 12, 2019
Age, race and viral genotype are associated with the prevalence of hepatitis B e antigen in children and adults with chronic hepatitis BAdrian M Di Bisceglie, Wendy C King, Mauricio Lisker-Melman, et al.
Hepatology (Baltimore, Md.)|April 3, 2021
Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Children With Chronic HCV: Part 2 of the DORA StudyMaureen M Jonas, Susan Rhee, Deirdre A Kelly, et al.
Hepatology (Baltimore, Md.)|March 27, 2024
Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesisJaclyn R Stonebraker, Rhonda G Pace, Paul J Gallins, et al.
Hepatology (Baltimore, Md.)|November 7, 2023
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendationsZachary M Sellers, David N Assis, Shruti M Paranjape, et al.
Journal of Pediatric Gastroenterology and Nutrition|November 26, 2025
Impact of elexacaftor/tezacaftor/ivacaftor on biomarkers of cystic fibrosis hepatobiliary involvement in the PUSH studyWen Ye, John C Magee, Suiyuan Huang, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|April 9, 2023
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver diseaseMarilyn J Siegel, Daniel H Leung, Jean P Molleston, et al.
Pageof 12